Gene Therapy
Studies from Autonomous University Yield New Data on Gene Therapy
Published in Gene Therapy Weekly, November 3rd, 2011
"Due to the complexity of the CNS, and in spite of the advances in the knowledge of its anatomy, pharmacology, and molecular and cellular biology, treatments for these diseases are still limited. The development of cell lines as a source for transplantation into the damaged CNS (cell therapy), and more recently their genetic modification to favor the expression and delivery of molecules with therapeutic potential (ex...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-11-03)
More Articles from Gene Therapy Weekly
- Epstein-Barr Virus
Data on Epstein-Barr Virus Reported by Researchers at University of the Republic - Gene Therapy
Data on Gene Therapy Detailed by Researchers at Hannover School of Medicine - Enzymes and Coenzymes
Findings from C.A. Gersbach and Co-Authors Provide New Insights into Enzymes and Coenzymes - Quinacrine Therapy
Findings from Pennsylvania State University in Quinacrine Therapy Reported - Small Interference RNAs (siRNAs)
Findings from Rutgers University Broaden Understanding of Small Interference RNAs (siRNAs) - Gene Therapy
Investigators at East China University of Science and Technology Publish New Data on Gene Therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
